Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer that is often misdiagnosed or overlooked. It is an advanced form of breast cancer that is characterized by the rapid onset of symptoms, including redness, swelling, and warmth in the breast.
IBC is a rare form of breast cancer, accounting for only 1-5% of all breast cancer cases. It is more common in women of African descent, and is more likely to occur in women over the age of 50. It is also more likely to occur in women who are obese, have a family history of breast cancer, or have a history of smoking.
The most common symptom of IBC is a rapid onset of redness, swelling, and warmth in the breast. Other symptoms may include a thickening of the skin, an orange-peel texture to the skin, and a feeling of heaviness in the breast. In some cases, the breast may also appear larger than normal.
IBC is usually diagnosed through a combination of physical examination, imaging tests, and biopsy. Imaging tests such as mammograms, ultrasounds, and MRI scans can help to identify the presence of cancer. A biopsy is then used to confirm the diagnosis.
Treatment for IBC typically involves a combination of chemotherapy, radiation, and surgery. Chemotherapy is used to shrink the tumor and reduce the risk of the cancer spreading. Radiation is used to kill any remaining cancer cells. Surgery is used to remove the tumor and any affected lymph nodes.
IBC is a serious form of breast cancer that requires prompt diagnosis and treatment. It is important to be aware of the signs and symptoms of IBC and to seek medical attention if any of these symptoms are present. Early diagnosis and treatment can help to improve the chances of a successful outcome.